Assessment of the anti-metastatic properties of sanguiin H-6 in HUVECs and MDA-MB-231 human breast cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Eun-Hwa | - |
dc.contributor.author | Park, Jun Yeon | - |
dc.contributor.author | Yoo, Hwa-Seung | - |
dc.contributor.author | Yoo, Jeong-Eun | - |
dc.contributor.author | Lee, Hye Lim | - |
dc.date.available | 2020-02-28T01:42:46Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016-07-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8099 | - |
dc.description.abstract | The anti-metastatic properties of sanguiin H-6 were examined in human umbilical vein vascular endothelial cells (HUVECs) and MDA-MB-231 human breast cancer cells. In HUVECs, sanguiin H-6 inhibited the density of migrated cells compared to that observed after treatment with the vehicle. In addition, sanguiin H-6 at a concentration of 6.25 mu M significantly blocked tube formation. Treatment with up to 25 mu M sanguiin H-6 had no effect on MDA-MB-231 cells, whereas treatment with 200 mu M sanguiin H-6 decreased cell viability. Sanguiin H-6 significantly decreased the expression levels of vascular endothelial growth factor (VEGF), phosphorylated Akt, and extracellular signal-regulated kinase 1/2 (ERK1/2) in MDA-MB-231 cells. These findings suggest that sanguiin H-6 is potentially useful as an anti-metastatic agent. (C) 2016 Elsevier Ltd. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.subject | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject | INDUCED ANGIOGENESIS | - |
dc.subject | VEGF | - |
dc.subject | INHIBITION | - |
dc.subject | INVASION | - |
dc.subject | RECEPTOR | - |
dc.subject | MACROPHAGES | - |
dc.subject | EXPRESSION | - |
dc.subject | INDUCTION | - |
dc.subject | MIGRATION | - |
dc.title | Assessment of the anti-metastatic properties of sanguiin H-6 in HUVECs and MDA-MB-231 human breast cancer cells | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000377471400018 | - |
dc.identifier.doi | 10.1016/j.bmcl.2016.05.050 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.26, no.14, pp.3291 - 3294 | - |
dc.identifier.scopusid | 2-s2.0-84969916746 | - |
dc.citation.endPage | 3294 | - |
dc.citation.startPage | 3291 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 26 | - |
dc.citation.number | 14 | - |
dc.contributor.affiliatedAuthor | Park, Jun Yeon | - |
dc.contributor.affiliatedAuthor | Lee, Hye Lim | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Sanguiin H-6 | - |
dc.subject.keywordAuthor | Metastasis | - |
dc.subject.keywordAuthor | HUVEC | - |
dc.subject.keywordAuthor | Breast cancer | - |
dc.subject.keywordAuthor | VEGF | - |
dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject.keywordPlus | INDUCED ANGIOGENESIS | - |
dc.subject.keywordPlus | VEGF | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | INVASION | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | MACROPHAGES | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | INDUCTION | - |
dc.subject.keywordPlus | MIGRATION | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.